Genomatix appoints Distributor for the growing Chinese Market
ZGZ is focusing on the research and development in biomedicine, new drug resources, biology information and biometrics research. Based on its experience and technological background, ZGZ is active in the international biochip-related field, and will contribute to the China biochip and bioscience community by connecting the western world with China.
"With more than 1.800 researchers in China being subscribed to our free services today, this represents a very important growth market for us", says Klaus May, Chief Business Officer of Genomatix.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.